82571-93-5

Upstream product

• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 400-94-2 4-fluoro-3-nitrobenzoyl chloride 
• 71-43-2 benzene 

Downstream Products

• 122800-12-8 3-(4-Benzoyl-2-nitro-phenylamino)-1-methyl-1H-pyrazole-4-carbonitrile 
• 31431-19-3 2-nitro-4-benzoylaniline 
• 122799-86-4 [2-Methyl-10-(4-methyl-piperazin-1-yl)-2,4-dihydro-2,3,4,9-tetraaza-benzo[f]azulen-7-yl]-phenyl-methanone 
• 90959-05-0 (9-Oxy-10-pyridin-3-yl-3,4-dihydro-2H-1,4a,9-triaza-phenanthren-7-yl)-phenyl-methanone 

Relevant academic research and scientific papers

Preparation method of 3-acetylindole BRPF1 inhibitor and use of 3-acetylindole BRPF1 inhibitor

The invention relates to a 3-acetylindole compound of a novel structure shown in a formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate or a solvate thereof, a preparation method of the compound, a pharmaceutical composition containing a therapeutically effective dose of the compound, and use thereof as a protein tyrosine kinase inhibitor, especially as a bromine-containing area PHD zinc finger protein 1 (BRPF1) inhibitor, in the prevention or treatment of disease benefited from the inhibition of BRPF1.

(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them

(1_H-azol-1-ylmethyl)substituted benzotriazole derivatives, compositions containing the same, and methods of treating estrogen dependent disorders.